Weekly Policy Update: The Close of the Second Regular Session and Unveiling Federal Drug Price Policies

Friday, May 11, 2018


Coming Together as a Community

Tuesday, May 08, 2018


Gates Biomanufacturing Facility readies first shipment of clinical trial cancer treatments

Monday, May 07, 2018

Groundbreaking moment represents years of planning, training and biomedical expertise 
Continue Reading

Weekly Policy Update: Industry Defeats Harmful Transparency Measures at the Capitol

Friday, May 04, 2018

CBSA had a busy legislative session advocating on behalf the industry against transparency measures that stood to stifle bioscience innovation in Colorado and failed to provide the relief patients need next time they pick up a prescription or schedule a procedure. On behalf of the Colorado BioScience Association, our members, and the bioscience industry, we thank the Colorado General Assembly and those leaders who opposed the harmful transparency measures. 

Making a Difference for Patients

Monday, April 30, 2018


Weekly Policy Update: HB-1358 Dies in Committee and Ongoing Transparency Advocacy

Friday, April 27, 2018

Advocating at the Capitol 
Continue Reading

Colorado BioScience Association Names New Board Members

Friday, April 20, 2018

Leaders represent CereScan, Ocugen, Prevacept Infection Control, Sharklet and Zimmer Biomet 
Continue Reading

Weekly Policy Update: Action on Two Bills and Advocacy in DC

Friday, April 20, 2018
Continue Reading

Prescription Drugs: Just the Facts

Friday, April 20, 2018


Driving Down Drug Costs

Monday, April 16, 2018
Continue Reading